CoMira™ Logix Smart® SARS-CoV-2 (genes RdRp/E) test kit
Boost speed and accuracy with real-time PCR testing
Key Features
Dual-Target Detection
Simultaneous detection of RdRp and E genes provides redundancy and enhanced confidence in results.
Co-Primers Technology
Advanced Co-Primers technology enhances specificity and minimizes non-specific amplification.
High Sensitivity
Detects low viral loads with exceptional analytical sensitivity for early infection detection.
Internal Controls
Includes Internal Positive Control (IPC) to validate sample quality and assay performance.
Applications
Clinical Diagnostics
Accurate COVID-19 diagnosis in clinical settings for symptomatic and asymptomatic patients.
Laboratory Testing
High-throughput testing capabilities for diagnostic and research laboratories.
Surveillance Programs
Support public health surveillance and monitoring of COVID-19 prevalence.
Benefits
Enhanced Reliability
Dual targets reduce false negatives and increase diagnostic confidence
Variant Resilience
Conserved gene targets remain effective across viral variants
Quality Assurance
Internal controls validate each test run
Rapid Turnaround
Fast results enable timely clinical decision-making
Technical Specifications
| Test Method | Real-time RT-PCR |
| Sample Type | Nasopharyngeal swabs, Oropharyngeal swabs, Bronchoalveolar lavage, Sputum, Saliva |
| Target Genes | RdRp (RNA-dependent RNA polymerase), E (Envelope) |
| Sensitivity | 99.45% (98.91–99.76%) |
| Specificity | 98.9% (98.0–99.5%) |
| Run Time | Approximately 90 minutes |
| Limit of Detection | 800–6,000 copies/mL (varies by extraction kit) |
| Compatible Instruments | CoMira Box, MIC, ECO48, CFX96 |
| Storage | Store at -20°C |
Request Product Information
Contact us to learn more about the CoMira Logix Smart SARS-CoV-2 RdRp/E test and how it can enhance your COVID-19 testing capabilities.
Contact Us